| Total (n = 1046) | Non-survivors (n = 61) | Survivors (n = 985) | p-value |
---|---|---|---|---|
Gender (male) – no. (%) | 563 (53.8) | 37 (60.7) | 526 (53.4) | 0.270 |
Age – yr - median (IQR) | 61.0 (50–72) | 68.0 (61.5–78.0) | 61.0 (46.0–69.0) | < 0.001 |
Comorbidities | ||||
 Hematologic malignancy – no. (%) | 178(17.0) | 10 (16.4) | 168 (17.1) | 0.960 |
 Chronic renal failure ≥ stage 3 – no. (%) | 204(19.5) | 13 (22.4) | 191 (19.4) | 0.713 |
 Immunocompromised – no. (%) | 392 (37.5) | 15 (24.6) | 377 (38.3) | 0.092 |
 Neutropenia due to systemic chemotherapy – no. (%) | 45 (4.3) | 1 (1.7) | 44 (4.5) | 0.999 |
CCI - median (IQR) | 4.0 (2–7) | 7.0 (5–9) | 4.0 (2–6) | < 0.001 |
Vasopressor need – no. (%) | 36 (3.4) | 8 (13.1) | 28 (2.8) | < 0.001 |
RDW (%) median (IQR) | 13.42 (12.30–15.11) | 14.74 (13.23–16.71) | 13.38 (12.27–14.99) | < 0.001 |
Disease severity scores | ||||
 qSOFA ≥2 – no (%) | 82 (7.8) | 16 (26.2) | 66 (6.7) | < 0.001 |
 SIRS score ≥ 2 – no (%) | 656 (58.6) | 46 (75.4) | 610 (61.9) | 0.035 |
 MEWS – median (IQR) | 2 (1–4) | 3 (1–5) | 2 (1–4) | < 0.001 |
 Sepsis according to emergency physician – no. (%) | 160 (15.3) | 17 (27.9) | 143 (14.5) | 0.005 |